Symbol="PIRS"
AssetType="Common Stock"
Name="Pieris Pharmaceuticals Inc"
Description="Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anti-calcium protein-based drugs in the United States. The company is headquartered in Boston, Massachusetts."
CIK="1583648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="255 STATE STREET, 9TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="13943200"
EBITDA="-48998000"
PERatio="None"
PEGRatio="0"
BookValue="0.207"
DividendPerShare="0"
DividendYield="0"
EPS="-0.52"
RevenuePerShareTTM="0.227"
ProfitMargin="-2.454"
OperatingMarginTTM="-3.058"
ReturnOnAssetsTTM="-0.294"
ReturnOnEquityTTM="-1.2"
RevenueTTM="16850000"
GrossProfitTTM="-27080000"
DilutedEPSTTM="-0.52"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.824"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.596"
PriceToBookRatio="2.08"
EVToRevenue="0.589"
EVToEBITDA="-0.49"
Beta="1.079"
num_52WeekHigh="2.05"
num_52WeekLow="0.162"
num_50DayMovingAverage="0.705"
num_200DayMovingAverage="1.063"
SharesOutstanding="82019000"
DividendDate="None"
ExDividendDate="None"
symbol="PIRS"
open="0.18"
high="0.18"
low="0.17"
price="0.17"
volume="3632371.00"
latest_trading_day="2023-07-07"
previous_close="0.18"
change="-0.01"
change_percent="-4.8433%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="68"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="32"
Volume_recent_avg="1035719"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_negative_thumbnail_id_2="1143"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="535"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_positive_thumbnail_id_1="659"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0049.jpeg"
image_positive_thumbnail_id_2="657"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0051.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
